Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.
Care must be taken when handling this product.
Do not contact skin or eyes.
Do not ingest or inhale.
Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g.
during transport) does not affect product quality)
It shall be only used by qualified personnel and only for research.
DMD-95-0010x 10mg per vial DMD-95-0020x 20mg per vial note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial *Customized dispensing is available
Manrner T.J. et al. Synthesis of 2’-deoxy-2’-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU, [18F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl. Med. Biol. 2003, 30,215-224.
Alauddin M.M. et al. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol. Imaging 2004, 3, 76-84.
Alauddin M.M. et al. Synthesis and evaluation of 2’-deoxy-2’-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J. Nucl. Med. 2004, 45, 2063-2069